Published: Vol 13, Iss 18, Sep 20, 2023 DOI: 10.21769/BioProtoc.4828 Views: 851
Reviewed by: Gal HaimovichMarion HoggRohini Ravindran Nair
Protocol Collections
Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics
Related protocols
Single Cell Isolation from Human Diabetic Fibrovascular Membranes for Single-Cell RNA Sequencing
Katia Corano Scheri [...] Amani A. Fawzi
Oct 20, 2024 1024 Views
RACE-Nano-Seq: Profiling Transcriptome Diversity of a Genomic Locus
Lu Tang [...] Philipp Kapranov
Jul 5, 2025 1331 Views
Analyzing RNA Localization Using the RNA Proximity Labeling Method OINC-seq
Megan C. Pockalny [...] J. Matthew Taliaferro
Aug 5, 2025 695 Views
Abstract
In eukaryotic cells, RNA biogenesis generally requires processing of the nascent transcript as it is being synthesized by RNA polymerase. These processing events include endonucleolytic cleavage, exonucleolytic trimming, and splicing of the growing nascent transcript. Endonucleolytic cleavage events that generate an exposed 5′-monophosphorylated (5′-PO4) end on the growing nascent transcript occur in the maturation of rRNAs, tRNAs, and mRNAs. These 5′-PO4 ends can be a target of further processing or be subjected to 5′-3′ exonucleolytic digestion that may result in termination of transcription. Here, we describe how to identify 5′-PO4 ends of intermediates in nascent RNA metabolism. We capture these species via metabolic labeling with bromouridine followed by immunoprecipitation and specific ligation of 5′-PO4 RNA ends with the 3′-hydroxyl group of a 5′ adaptor (5′-PO4 Bru-Seq) using RNA ligase I. These ligation events are localized at single nucleotide resolution via highthroughput sequencing, which identifies the position of 5′-PO4 groups precisely. This protocol successfully detects the 5′monophosphorylated ends of RNA processing intermediates during production of mature ribosomal, transfer, and micro RNAs. When combined with inhibition of the nuclear 5′-3′ exonuclease Xrn2, 5′-PO4 Bru-Seq maps the 5′ splice sites of debranched introns and mRNA and tRNA 3′ end processing sites cleaved by CPSF73 and RNaseZ, respectively.
Key features
• Metabolic labeling for brief periods with bromouridine focuses the analysis of 5′-PO4 RNA ends on the population of nascent transcripts that are actively transcribed.
• Detects 5′-PO4 RNA ends on nascent transcripts produced by all RNA polymerases.
• Detects 5′-PO4 RNA ends at single nucleotide resolution.
Background
Tracking genome-wide active transcription and its regulation has been made possible by several complementary approaches (Wissink et al., 2019). These include isolation of chromatin-associated RNAs (Bhatt et al., 2012, Mayer et al., 2015, Weber et al., 2014), RNA polymerase–associated RNAs (Churchman and Weissman, 2011, Nojima et al., 2015, Fong et al., 2017), or nascent transcripts pulse-labeled with nucleoside analogs such as 4-thiouridine (Schwalb et al., 2016, Kenzelmann et al., 2007, Rabani et al., 2011, Herzog et al., 2017, Muhar et al., 2018, Schofield et al., 2018), 5-ethenyluridine (Jao and Salic, 2008), or bromouridine (Paulsen et al., 2014).
In eukaryotic cells, endonucleolytic cleavage of the nascent transcript is used to release fully transcribed RNAs from chromatin or to release small RNAs from longer precursors during transcription [i.e., micro RNAs (miRNAs) and intron-encoded small nucleolar RNAs (snoRNAs)]. Most of these cleavage events are carried out by nucleases that leave 5′-phosphate (5′-PO4) and 3′ OH ends, including CPSF73, Int11, RNaseP, RNaseZ, and Drosha.
Recently, POINT-5 technology identified 5′ ends generated at cleavage sites of RNA pol II–associated transcripts from runoff products of 5′ RACE in reverse transcription reactions (Sousa-Luis et al., 2021), but this approach does not inform on the identity of the chemical group at these 5′ RNA ends. Previously, methods have been developed to specifically map 5′-PO4 RNA ends by virtue of their ability to be ligated to adaptors by RNA ligase I (Harigaya and Parker, 2012, German et al., 2008).
Here, we describe 5′-PO4 Bru-Seq for direct detection of 5′-PO4 groups in nascent transcripts produced by all RNA polymerases in the cell (Figure 1). The method was previously validated and used to identify targets of the Xrn2 exonuclease (Cortazar et al., 2022). In this method, total RNA is fragmented with Micrococcal Nuclease (MNase) that produces 5′ OH and 3′ PO4 ends, and nascent transcripts are enriched by immunoprecipitation of 5-bromouridine pulse-labeled molecules, followed by repair of 3′ phosphates with T4 polynucleotide kinase, ligation of 5′ and 3′ adaptors, and PCR amplification of sequencing libraries. Only RNA fragments with native 5′-PO4 ends can be incorporated into these libraries (Harigaya and Parker, 2012). Unique molecular identifiers (UMIs) are included to allow removal of PCR duplicates. The molecular events that result in 5′-PO4 groups on nascent RNA ends detected by this method potentially include cleavage by endonucleases, intron debranching, and decapping.
Figure 1. The 5′-PO4 Bru-Seq protocol. 5′-PO4 Bru-Seq enriches transcripts being extended by actively transcribing polymerases via metabolic labeling with bromouridine, fragmentation by micrococcal nuclease (MNase), and immunoprecipitation. The 3′-ends generated by MNase cleavage events are repaired by T4 polynucleotide kinase (PNK) in the absence of ATP. 5′-PO4 ends of nascent transcripts are then ligated to the 3′-hydroxyl group of a 5′ adaptor, amplified by PCR, and deep sequenced using Illumina sequencing technology.
Materials and reagents
Mammalian cell type of interest (e.g., HEK293, ATCC, catalog number: CRL-1573)
Cell culture media supplemented with 10% serum (e.g., DMEM supplemented with 10% FBS; DMEM, Thermo Fisher Scientific, catalog number: 11995040; FBS, VWR, catalog number: 97068-085)
10 cm tissue culture dishes (e.g., Genesee Scientific, catalog number: 25-200)
5/10 mL sterile serological pipets (e.g., Genesee Scientific, catalog numbers: 12-102, 12-104)
15/50 mL conical bottom centrifuge tubes (e.g., Corning, catalog numbers: 05-538-59A, 05-526B)
1.7 mL microcentrifuge tubes (e.g., Genesee Scientific, catalog number: 22-282)
TRIzol reagent (Thermo Fisher Scientific, catalog number: 15596018)
Chloroform (Fisher Scientific, catalog number: BP1145-1)
Isopropanol (Fisher Scientific, catalog number: BP2618-1)
80% ethanol, molecular biology grade (e.g., Thermo Fisher Scientific, catalog number: T08204K7)
GeneRuler 1 kb Plus DNA ladder (Thermo Fisher Scientific, catalog number: FERSM1333)
5 M NaCl, RNase-free (Thermo Fisher Scientific, catalog number: AM9760G)
Micrococcal nuclease (MNase) (2,000,000 gel units/mL) (New England Biolabs, catalog number: M0247S)
10× MNase reaction buffer (New England Biolabs, catalog number: B0247S)
0.5 M EGTA, pH 8.0, DNase and RNase Free (Thermo Fisher Scientific, catalog number: NC1874048)
Nuclease-free water (Thermo Fisher Scientific, catalog number: AM9939)
10× phosphate-buffered saline (PBS), pH 7.4, RNase-free (Thermo Fisher Scientific, catalog number: AM9624)
5-bromouridine (Sigma-Aldrich, catalog number: 850187)
Triton X-100 (Sigma-Aldrich, catalog number: X100)
1 M DTT (Thermo Fisher Scientific, Catalog number: P2325)
Superase-InTM RNase inhibitor (Invitrogen, AM2696)
Protein G magnetic beads (Pierce Thermo Scientific, catalog number: 88848)
Purified mouse anti-BrdU antibody (clone 3D4, RUO) (BD Pharmingen, catalog number: 555627)
QubitTM RNA High Sensitivity Assay kit (Thermo Fisher Scientific, catalog number: Q32852)
InvitrogenTM QubitTM assay tubes (Thermo Fisher Scientific, catalog number: Q32856)
T4 polynucleotide kinase (Thermo Fisher Scientific, catalog number: EK0031)
10× reaction buffer A (Thermo Fisher Scientific, catalog number: EK0031)
RNA Clean & ConcentratorTM-5 kit (ZYMO RESEARCH, catalog number: R1013, R1014)
QIAseq miRNA library kit (Qiagen, catalog number: 331502)
QIAseq miRNA Index kit IL UDI (e.g., UDI-B-96, Qiagen, catalog number: 331625)
10× TBE Buffer (Thermo Fisher Scientific, catalog number: AM9863)
1:20 dilution of MNase (100,000 gel units/mL) (see Recipes)
50 mM 5-bromouridine (see Recipes)
IP buffer (see Recipes)
Software
Removal of UMI duplicates: UMI-tools (Smith et al., 2017)
Removal of adaptor sequences: Cutadapt (Martin, 2011)
Genomic alignment of sequencing reads: Bowtie2 (Langmead and Salzberg, 2012)
BAM file processing: Samtools (Li et al., 2009)
Integrative Genomics Viewer (IGV) (Robinson et al., 2011)
Conversion of BAM files to BED files: bedtools (Quinlan and Hall, 2010)
Conversion of bedGraph files to BigWig: bedGraphToBigWig (Kent et al., 2010)
Equipment
1.5 mL microcentrifuge magnet stand (e.g., Thermo Fisher Scientific, catalog number: 12321D)
Centrifuge 5430 R (e.g., Eppendorf, catalog number: 022620601)
Thermal cycler (e.g., Bio-Rad, model: C1000 Touch, catalog number: 1851148)
Qubit fluorometer (Thermo Fisher Scientific, catalog number: Q33238)
Procedure
Labeling of nascent transcripts
The following steps achieve labeling of nascent transcripts with bromouridine to enable isolation of these transcripts via immunoprecipitation in Section D. 5-bromouridine is incorporated by all RNA polymerases actively transcribing during incubation of cells with 5-bromouridine.
Grow cells in 10 cm culture plates in a total of 10 mL of culture medium. For section C, 250 μg of total RNA is required. Scale the number of plates according to the type of cell line and yield from the protocol of total RNA extraction. For HEK293 cells, use a total of 3 × 10 cm plates or a single 15 cm plate per condition (~20 × 106 cells).
When the cell population has reached approximately 70% confluency, remove the cell medium and replace it with 10 mL of fresh cell medium containing 400 μL of 50 mM 5-bromouridine (2 mM 5-bromouridine final concentration). If using a 15 cm plate, scale up accordingly by using 20 mL of fresh cell medium containing 800 μL of 50 mM 5-bromouridine.
Place plate with cells in a humidifying incubator at 37 °C and 5% CO2 for 30 min (see Note 1).
Obtain a no-bromouridine negative control sample to rule out unspecific enrichment of RNA after immunoprecipitation. Perform the labeling protocol with the number of plates used per condition, excluding 5-bromouridine from the fresh cell medium in step A2.
Remove cell medium, add 1 mL of TRIzol reagent to dissociate cells from the culture plate, and transfer to a 1.5 mL microcentrifuge tube. If using a 15 cm plate, harvest in at least 3 mL of TRIzol reagent.
Pipette the lysate up and down to homogenize.
The following sections should be performed with special care to not contaminate RNA samples, which could result in RNA degradation by RNases. Use RNase-free certified plasticware and filter tips.
Total RNA extraction
Add 0.2 mL of chloroform per 1 mL of TRIzol lysate, securely cap the tube, and thoroughly mix by shaking for ~30 s.
Centrifuge the sample at 12,000× g for 15 min at 4 °C.
Transfer the aqueous phase containing the RNA to a new 1.5 mL microcentrifuge tube by angling the tube at 45° and pipetting the solution out.
Add an equal volume of isopropanol to the aqueous phase, mix by pipetting up and down, and incubate for 10 min at 4 °C.
Centrifuge at 12,000× g for 10 min at 4 °C.
Total RNA precipitate forms a white, gel-like pellet at the bottom of the tube.
Remove the solution by pipetting. Avoid removing the RNA pellet, which should be located below the hinge of the microcentrifuge tube as a white pellet.
Gently add 1 mL of ice-cold 80% ethanol and centrifuge at 12,000× g for 5 min at 4 °C.
Remove the 80% ethanol solution by pipetting out and pulse-spin the 1.7 mL microcentrifuge tube in a mini-centrifuge, to bring any residual ethanol from the sides of the tube down to the bottom.
Using a P20 pipette and tip, remove the remaining solution.
Resuspend the RNA pellet in 100 μL of RNase-free water, or in 300 μL if starting from a 15 cm plate.
Quantify the concentration of RNA using a Nanodrop spectrophotometer.
We suggest ruling out RNA fragmentation during the extraction of total RNA by analyzing RNA quality by your method of choice (i.e., Bioanalyzer, TapeStation, or RNA gel electrophoresis analysis). For RNA gel electrophoresis, we load 2 μL of the total RNA sample and 3 μL of GeneRuler 1 kb Plus DNA ladder into a 1% agarose gel in 1× TBE buffer and apply 140 V for 1 h (Figure 2A) (see Note 2). Store the RNA samples in a freezer at -80 °C or continue with Section C.
Figure 2. Gel electrophoresis of MNase digested total RNA. Nascent transcripts of HEK293 cells were pulse-labeled with 5-bromouridine for 30 min and total RNA was extracted. Shown is the purified total RNA sample before (A) and after fragmentation with MNase (B), for three biological replicates.
RNA fragmentation with MNase
Fragmentation of total RNA with MNase before immunoprecipitation results in enrichment of only the region of pre-mRNA molecules that is labeled with 5-bromouridine. In addition, MNase digestion creates RNA molecules of a suitable size for library preparation in Section G.
The procedures described in Sections C and D have been performed uninterrupted. Before starting, consider that this protocol does not include a stopping point between these sections. If a stopping point is necessary, we propose to complete step C4 in this section and place the fragmented RNA on ice until this sample is used in step D6 within 24 h.
Mix 250 μg of total RNA, 25 μL of 5 M NaCl, and 50 μL of 10× MNase reaction buffer in a 1.7 mL tube and bring to a total volume of 500 μL with nuclease-free water. Mix by pipetting up and down.
Incubate samples at 37 °C for 5 min.
Add 5 μL of a 1:20 dilution of MNase (100,000 gel units/mL), mix by pipetting up and down, and incubate for 1 min.
Stop the reaction by adding 10 μL of 0.5 M EGTA. Mix well and place sample on ice until completing step D5.
Evaluate RNA fragmentation by performing a gel electrophoresis using 2–4 μL of fragmented RNA (1–2 μg). RNA fragments should range from ~1.5 kb to ~100 bp in length. (Figure 2B).
Immunoprecipitation of nascent transcripts
The following steps enrich bromouridine-labeled nascent RNA transcripts via specific binding to a mouse BrdU antibody conjugated to protein G magnetic beads while washing away unlabeled RNA.
Wash protein G magnetic beads with IP buffer. Transfer 50 μL of well-mixed protein G magnetic beads–containing solution into a 1.7 mL tube and follow the steps below to wash the beads:
Place the 1.7 mL tube on the magnet stand to immobilize the beads.
When the solution has cleared completely and all beads are immobilized on the wall of the tube, remove the supernatant by pipetting out and add 500 μL of IP buffer.
Remove the tube from the magnet stand and resuspend beads by pipetting up and down gently until all beads are dissociated and no clumps of beads are observed. Place back on the magnet stand.
When the solution has cleared completely and all beads are immobilized on the wall of the tube, remove the supernatant by pipetting out.
Add 1 mL of IP buffer to the washed beads and remove from the magnet stand.
Conjugate mouse anti-BrdU antibody to protein G magnetic beads. Add 8 μL of antiBrdU antibody (4 μg) to the 1 mL of IP buffer containing the protein G magnetic beads, mix by pipetting up and down, and incubate the sample at 4 °C rotating end-to-end for 1 h. If the stopping point proposed in section C is included, this incubation can be performed overnight.
Wash conjugated anti-BrdU antibody and beads with IP buffer by performing the wash procedure described in step D1 (a–d) three times.
Add 1 mL of IP buffer to the beads and remove tube from the magnet stand.
Add the fragmented RNA from step C4 to the tube containing the beads, mix by pipetting up and down, and incubate the sample at 4 °C rotating end-to-end for 1 h (see Note 3).
Wash beads with IP buffer by performing the wash procedure described in step D1 (a–d) three times. Leave the tube on the magnet stand after the last wash.
Without disturbing the beads, add 500 μL of RNase-free 1× PBS, incubate for 30 s, and remove the supernatant by pipetting out.
Remove tube from the magnet stand, add 20 μL of nuclease-free water, resuspend beads by pipetting up and down, and transfer to a PCR tube.
Place the tube on a thermal cycler and run the following program to elute the antibody and nascent transcripts from the beads: 90 °C for 5 min, 12 °C for 30 s, with heated lid at 105 °C.
Vortex and transfer the sample to a 1.5 mL tube.
Place the 1.5 mL tube on the magnet stand and, when the solution has cleared, transfer the supernatant into a clean 1.5 mL tube.
Measure the RNA concentration of the sample using the QubitTM RNA High Sensitivity Assay kit. The expected concentration of specific enrichment of nascent transcript from HEK293 cells following this protocol is ~9–15 ng/μL with a total RNA yield of ~180–300 ng. The no-bromouridine negative control sample should not contain detectable signal by the Qubit Assay (< 0.2 ng/μL). Detection of RNA in this negative control suggests low efficiency of the washes after the immunoprecipitation.
Repair of MNase-fragmented RNA 3′-end
RNA fragmentation by MNase creates 3′ phosphate groups (Alexander et al., 1961). These can be converted to 3′OH RNA ends by T4 polynucleotide kinase, required for ligation to a 3′ adaptor during library preparation in section G. This reaction is performed in the absence of ATP, precluding installation of non-native 5′-PO4 groups on RNA molecules by this enzyme.
Transfer 150 ng of nascent transcripts into a 1.5 mL tube, add 5 μL of 10× reaction buffer A, add RNase-free water to bring the solution up to 49 μL, and mix by pipetting up and down.
Add 1 μL of T4 polynucleotide kinase (10 U) and incubate at 30 °C for 30 min.
In-column RNA purification
Purify the RNA from the in vitro reaction using any affinity micro-column purification protocol that elutes the RNA in a small quantity (< 20 μL). We used the RNA Clean & ConcentratorTM-5 cleanup kit described below.
Add two volumes of RNA binding buffer to each sample and mix by pipetting up and down.
Add an equal volume of ethanol (95%–100%) and mix by pipetting up and down.
Transfer the sample to the Zymo-SpinTM IC column in a collection tube and centrifuge at 12,000× g for 30 s. Discard the flowthrough.
Skip the DNase I treatment step, add 400 μL of RNA prep buffer to the column, and centrifuge at 12,000× g for 30 s. Discard the flowthrough.
Add 700 μL of RNA wash buffer to the column and centrifuge at 12,000× g for 30 s. Discard the flowthrough.
Add 400 μL of RNA wash buffer to the column and centrifuge at 12,000× g for 1 min. Ensure complete removal of the wash buffer. Carefully, transfer the column into a RNase-free tube.
Add 15 μL of DNase/RNase-free water directly to the column matrix and centrifuge at 12,000× g for 1 min to elute the RNA.
Measure the RNA concentration of the sample using the QubitTM RNA High Sensitivity Assay kit (expected to be approximately 6 ng/μL). Continue to section G or freeze the RNA sample at -80 °C.
Preparation of 5′-PO4 Bru-Seq libraries
Preparation of 5′-PO4 Bru-Seq libraries can be achieved using a library preparation protocol to detect miRNAs. In this protocol, we employed the QIAseq miRNA library kit, including 10-base UMIs. Transcripts with 5′ ends other than a monophosphate, including cap structures, are excluded because they cannot be ligated to the 5′ adaptor. Follow the steps in the manufacturer’s protocol with the specific conditions described below:
Prepare reagents required for the 3′ ligation reactions. Thaw QIAseq miRNA NGS 3′ adapter, QIAseq miRNA NGS 3′ buffer, 2× miRNA ligation activator, and nuclease-free water at room temperature (15–25 °C). Mix each solution by flicking the tubes. Centrifuge the tubes briefly to collect any residual liquid from the sides of the tubes and keep at room temperature.
Use 10–50 ng of nascent RNA transcripts using a 1:5 dilution of the 3′ adapter according to the QIAseq miRNA library kit Table 5 (Dilution of the QIAseq miRNA NGS 3′ Adapter).
On ice, prepare the 3′ ligation reaction according to Table 1. Briefly centrifuge, mix by pipetting up and down 15–20 times, and centrifuge briefly again.
Table 1. Setup of 3′ ligation reactions
Components | Volume/reaction |
---|---|
Nuclease-free water | Variable |
QIAseq miRNA NGS 3′ adapter | 1 μL |
QIAseq miRNA NGS RI | 1 μL |
QIAseq miRNA NGS 3′ ligase | 1 μL |
QIAseq miRNA NGS 3′ buffer | 2 μL |
2x miRNA ligation activator | 10 μL |
Template RNA (added in step G4) | Variable |
Total volume | 20 μL |
Add template RNA to each tube containing the 3′ ligation master mix. Briefly centrifuge, mix by pipetting up and down 15–20 times, and centrifuge briefly again.
Incubate for 1 h at 28 °C.
Incubate for 20 min at 65 °C.
Hold at 4 °C for at least 5 min.
Prepare reagents required for the 5′ ligation reactions. Thaw QIAseq miRNA NGS 5′ adapter and QIAseq miRNA NGS 5′ buffer at room temperature. Mix by flicking the tube. Centrifuge the tube briefly to collect residual liquid from the sides of the tube and keep at room temperature.
Use a 1:2.5 dilution of the 5′ adapter according to the QIAseq miRNA library kit Table 7 (Dilution of the QIAseq miRNA NGS 5′ Adapter).
On ice, prepare the 5′ ligation reaction according to Table 2, adding the components in the order listed. Briefly centrifuge, mix by pipetting up and down 10–15 times, and centrifuge briefly again.
Table 2. Setup of 5′ ligation reactions
Component | Volume/reaction |
---|---|
3′ ligation reaction (already in the tube) | 20 μL |
Nuclease-free water | 15 μL |
QIAseq miRNA NGS 5′ buffer | 2 μL |
QIAseq miRNA NGS RI | 1 μL |
QIAseq miRNA NGS 5′ ligase | 1 μL |
QIAseq miRNA NGS 5′ adapter | 1 μL |
Total volume | 40 μL |
Incubate for 30 min at 28 °C.
Incubate for 20 min at 65 °C.
Hold at 4 °C and proceed immediately to step G14.
Prepare reagents required for the reverse transcription reactions. Thaw QIAseq miRNA NGS RT initiator, QIAseq miRNA NGS RT buffer, and QIAseq miRNA NGS RT primer at room temperature. Mix by flicking the tube. Centrifuge the tubes briefly to collect residual liquid from the sides of the tubes and keep at room temperature.
Add 2 μL of QIAseq miRNA NGS RT initiator to each tube. Briefly centrifuge, mix by pipetting up and down 15–20 times, and centrifuge briefly again.
Incubate the tubes as described in Table 3.
Table 3. Incubation of tubes with QIAseq miRNA NGS RT initiator
Time | Temperature |
---|---|
2 | 75 °C |
2 | 70 °C |
2 | 65 °C |
2 | 60 °C |
2 | 55 °C |
5 | 37 °C |
5 | 25 °C |
∞* | 4 °C |
*Hold until setup of the RT reaction
Use a 1:5 dilution of the QIAseq miRNA NGS RT primer according to the QIAseq miRNA library kit Table 10 (Dilution of the QIAseq miRNA NGS RT Primer).
On ice, prepare the reverse transcription reaction according to Table 4. Briefly centrifuge, mix by pipetting up and down 12 times, and centrifuge briefly again.
Table 4. Setup of reverse transcription reactions
Component | Volume/reaction |
---|---|
5′ ligation reaction + QIAseq miRNA NGS RT initiator (already in the tube) | 42 μL |
QIAseq miRNA NGS RT primer | 2 μL |
Nuclease-free water | 2 μL |
QIAseq miRNA NGS RT buffer | 12 μL |
QIAseq miRNA NGS RI | 1 μL |
QIAseq miRNA NGS RT enzyme | 1 μL |
Total volume | 60 μL |
Incubate for 1 h at 50 °C.
Incubate for 15 min at 70 °C.
Hold at 4 °C for at least 5 min.
Prepare QIAseq miRNA NGS beads (QMN beads). Thoroughly vortex QIAseq beads and QIAseq miRNA NGS bead binding buffer to ensure that the beads are in suspension and homogenously distributed. Do not centrifuge the reagents. Important: QIAseq beads need to be homogenous. This necessitates working quickly and thoroughly resuspending the beads immediately before use. If a delay in the protocol occurs, simply vortex the beads again.
Carefully add 400 μL of QIAseq beads (bead storage buffer is viscous) to a 2 mL microfuge tube. This quantity of beads is sufficient to perform “Protocol: cDNA Cleanup” and the cleanup associated with library amplification for one sample. Briefly centrifuge and immediately separate beads on a magnet stand.
When beads have fully migrated, carefully remove and discard the supernatant.
Remove the tube from the magnet stand and carefully pipette (buffer is viscous) 150 μL of QIAseq miRNA NGS bead binding buffer onto the beads. Thoroughly vortex to completely resuspend the bead pellet. Briefly centrifuge and immediately separate the beads on a magnet stand.
When beads have fully migrated, carefully remove and discard the supernatant.
Remove the tube from the magnet stand and carefully pipette 400 μL of QIAseq miRNA NGS bead binding buffer onto the beads (buffer is viscous). Thoroughly vortex to completely resuspend the bead pellet. Preparation of the QMN beads is now complete. If the beads will not be used immediately, store them on ice or at 2–8 °C.
Perform a cDNA cleanup. Centrifuge the tubes containing the cDNA reactions and add 143 μL of QMN beads to tubes containing the cDNA reactions. Vortex for 3 s and centrifuge briefly.
Incubate for 5 min at room temperature.
Place the tubes on a magnet stand for ~4 min or until the beads have fully migrated.
Discard the supernatant and keep the beads.
With the beads still on the magnet stand, add 200 μL of 80% ethanol. Immediately remove and discard the ethanol wash.
Repeat the wash by adding 200 μL of 80% ethanol. Immediately remove and discard the second ethanol wash. Important: completely remove all traces of ethanol after the second wash. Briefly centrifuge and return the tubes to the magnetic stand. Remove the ethanol with a 200 μL pipette first, and then use a 10 μL pipette to remove any residual ethanol.
With the beads still on the magnetic stand, air-dry at room temperature for 10 min. Residual ethanol can hinder amplification efficiency in the subsequent library amplification reactions. Depending on humidity, extended drying time may be required.
With the beads still on the magnetic stand, elute the DNA by adding 17 μL of nuclease-free water to the tubes. Subsequently close/cover and remove the tubes/plates from the magnetic stand.
Carefully pipette up and down until all the beads are thoroughly resuspended, briefly centrifuge, and incubate at room temperature for 2 min.
Return the tubes to the magnetic stand for ~2 min or until the beads have fully migrated. The completed cDNA cleanup product can be stored at -20 °C; alternatively, continue with the steps below.
Prepare reagents required for the library amplification reactions. Thaw QIAseq miRNA NGS library buffer, QIAseq miRNA NGS ILM library forward primer, and required index primer(s). Mix by flicking the tube. Centrifuge the tubes briefly to collect residual liquid from the sides of the tubes.
On ice, prepare the library amplification reaction according to Table 5. Briefly centrifuge, mix by pipetting up and down 12 times, and centrifuge briefly again.
Table 5. Setup of library amplification reactions when using tube indices
Component | Volume/reaction |
---|---|
Product from “Protocol: cDNA Cleanup” | 15 μL |
QIAseq miRNA NGS library buffer | 16 μL |
HotStarTaq DNA polymerase | 3 μL |
QIAseq miRNA NGS ILM library forward primer | 2 μL |
QIAseq miRNA NGS ILM IPD1 through IPD48 (Index Primer) | 2 μL |
Nuclease-free water | 42 μL |
Total volume | 80 μL |
Program the thermal cycler according to Table 6.
Table 6. Library amplification protocol
Step | Time | Temperature |
Hold | 15 min | 95 °C |
3-step cycling (18 cycles) | ||
Denaturation | 15 s | 95 °C |
Annealing | 30 s | 60 °C |
Extension | 15 s | 72 °C |
Hold | 2 min | 72 °C |
Hold | ∞ | 4 °C |
Place the library amplification reaction in the thermal cycler and start the run. Upon completion of the protocol, hold at 4 °C for at least 5 min.
Add 75 μL of QMN beads to tubes. Ensure the QMN beads are thoroughly mixed at all times. This necessitates working quickly and resuspending the beads immediately before use. If a delay in the protocol occurs, simply vortex the beads.
Briefly centrifuge the 80 μL library amplification reactions and transfer 75 μL to the tubes containing the QMN beads. Vortex for 3 s and briefly centrifuge.
Incubate for 5 min at room temperature.
Place tubes on a magnet stand for approximately 4 min or until the beads have fully migrated.
Keep the supernatant and transfer 145 μL of the supernatant to new tubes. Discard the tubes containing the beads. Important: do not discard the supernatant at this step.
To the 145 μL supernatant, add 130 μL of QMN beads. Vortex for 3 s and briefly centrifuge.
Incubate at room temperature for 5 min.
Place the tubes on a magnet stand until beads have fully migrated.
Discard the supernatant and keep the beads.
With the beads still on the magnet stand, add 200 μL of 80% ethanol. Immediately remove and discard the ethanol wash.
Repeat the wash by adding 200 μL of 80% ethanol. Immediately remove and discard the second ethanol wash. It is important to completely remove all traces of the ethanol wash after the second wash. Briefly centrifuge and return the tubes to the magnetic stand. Remove the ethanol with a 200 μL pipette first, and then use a 10 μL pipette to remove any residual ethanol.
With the beads still on the magnetic stand, air-dry at room temperature for 10 min.
With the beads still on the magnetic stand, elute the DNA by adding 17 μL of nuclease-free water to the tubes. Subsequently close and remove the tubes from the magnetic stand.
Carefully pipette up and down until all beads are thoroughly resuspended; briefly centrifuge and incubate at room temperature for 2 min.
Place the tubes on the magnetic stand for ~2 min (or until beads have cleared).
Transfer 15 μL of eluted DNA to new tubes. This is the 5′-PO4 Bru-Seq sequencing library. Store sequencing libraries at -20 °C.
Submit libraries for Illumina sequencing. It is recommended to use paired-end sequencing. The 5′ end of the sequenced Read 1 informs on the position of the ligation event (5′-PO4 RNA end) and the first 12 nucleotides at the 5′ end of Read 2 inform on the identity of the UMI.
Data analysis
Extract UMIs from the Illumina sequencing run files (e.g., Read1.fastq, Read2.fastq) and obtain a new Read1.UMI.fastq file using UMI-tools (see Note 4).
umi_tools extract \
-I Read2.fastq \
--extract-method=string \
--bc-pattern=NNNNNNNNNNNN \
--read2-in=Read1.fastq \
--read2-out=Read1.UMI.fastq \
> Read2.UMI.fastq
Remove adaptor sequences using Cutadapt.
cutadapt \
-a 'AACTGTAGGCACCATCAAT' \
-A 'GATCGTCGGACTGTAGAACTCTGAAC' \
-o Read1.trimmed.fastq \
-p Read2.trimmed.fastq \
Read1.UMI.fastq \
Read2.UMI.fastq \
Use Bowtie (e.g., Bowtie 2) to align reads in the Read1.trimmed.fastq file to the human genome index (e.g., GRCh37/hg19).
bowtie2 \
-x bowtie_index \
-U Read1.trimmed.fastq \
-S Read1.sam
Convert the “Read1.sam” file to BAM format.
samtools view -S -b Read1.sam > Read1.bam
Sort the Read1.bam file.
samtools sort Read1.bam -o Read1.sorted.bam
Remove UMI duplicates using UMI-tools.
umi_tools dedup \
--method unique \
--read-length \
-I Read1.sorted.bam \
-S Read1.filtered.bam
Use the Read1.filtered.bam and the Read1.filtered.bam.bai files to visualize sequence reads on IGV. Figure 3 below shows sequenced reads mapped to the poly(A) site of the ACTB gene, where the first 5′ nucleotide in the sequenced read contains the single nucleotide coordinates of the 5′-PO4 RNA end in the nascent transcript immediately downstream of the poly(A) cleavage site (red arrows).
Figure 3. Integrative Genomics Viewer (IGV) screenshot showing sequenced 5′-PO4 Bru-Seq reads mapped to the 3′ end of the ACTB gene, where the localized 5′-monophosphorylated nucleotides in the nascent transcript are indicated by read arrows. The poly(A) signal is indicated by a red line above the sequence track.
Convert the “Read1.filtered.bam” file to BED format using bedtools.
bedtools bamtobed \
-i Read1.filtered.bam \
> Read1.filtered.bed
Collapse read coordinates in the “Read1.filtered.bed” file to the 5′ single nucleotide coordinate, which corresponds to the 5′-PO4 RNA single nucleotide coordinate, and create coverage BEDGRAPH files with strand specificity using the “chrom.sizes” file associated with the reference genome that was used for mapping.
bedtools genomecov \
-strand + \
-5 \
-i Read1.filtered.bed \
-bg chrom.sizes \
> Read1.5p.positive.bg
bedtools genomecov \
-strand - \
-5 \
-i Read1.filtered.bed \
-bg chrom.sizes \
> Read1.5p.negative.bg
Sort the output BEDGRAPH files.
sort -k1,1 -k2,2n Read1.5p.positive.bg \
> Read1.5p.sorted.positive.bg
sort -k1,1 -k2,2n Read1.5p.negative.bg \
> Read1.5p.sorted.negative.bg
Use bedGraphToBigWig to create BigWig files for visualization of genomic data on the University of California Santa Cruz (UCSC) Genome Browser.
bedGraphToBigWig \
Read1.5p.sorted.positive.bg \
chrom.sizes \
Read1.5p.positive.bw
bedGraphToBigWig \
Read1.5p.sorted.negative.bg \
chrom.sizes \
Read1.5p.negative.bw
Confirm enrichment of 5′-PO4 Bru-Seq signal by detection of 5′-PO4 RNA ends at microprocessor cleavage sites of the MIR17HG miRNA cluster (Figure 4A), at the 5′ end of the SNORA14B snoRNA (Figure 4B), the 5′ end of the primary tRNA transcript prior to RNaseP cleavage (Figure 4C, red arrow), and 5′-PO4 ends generated after cleavage at the poly(A) site on the ACTB gene (Figure 4D). 5′-PO4 signal can be further validated by detection of the 5′ end of the 47S rRNA precursor (Wang and Pestov, 2011) (Figure 4E, red arrow). Ribosomal signal can be visualized by mapping to the human ribosomal repeating unit reference sequence (GenBank accession no. U13369). Finally, relative quantification of peak intensities across libraries can be made by normalizing to the total number of mapped reads or by normalization to an appropriate internal control region [e.g., the mitochondrial genome (Cortazar et al., 2022)].
Notes
Incubation of cells with 2 mM 5-bromouridine for a period of 30 min has been previously validated to result in mainly nascent transcript signal (Paulsen et al., 2013). Shorter incubation times can be performed (~20 min), although the yield of nascent transcripts is substantially decreased. Longer incubation times are not recommended, given that labeled nascent transcripts are processed, accumulate in the population of mature RNA, and contaminate nascent transcript signal.
The population of intact RNA molecules in high-quality samples show distinct bands that correspond to the 28S and 18S rRNA species, respectively. A fuzzy and faint band at the bottom of the gel corresponding to the population of tRNAs can also be visualized depending on the amount of RNA loaded (Figure 2A). The qualitative 28S/18S band intensity ratio value of 2 has been historically considered to indicate intact RNA.
Shorter incubations during immunoprecipitation of bromo-labeled RNA reduce the potential for RNA fragmentation.
By default, UMI_tools extracts UMIs from the “Read1.fastq” input file using argument “-I.” Given that the UMI is contained in Read 2, you can simply switch the input file provided for argument “--read2-in.”
Recipes
1:20 dilution of MNase (100,000 gel units/mL)
Mix 1 μL of MNase (2,000,000 gel units/mL) with 19 μL of 1× MNase reaction buffer.
50 mM 5-bromouridine
Dissolve 808 mg of 5-bromouridine in 50 mL of RNase-free 1× PBS and store at -20 °C.
IP Buffer
0.05% Triton X-100, 1 mM DTT, supplemented with Superase-InTM RNase inhibitor in RNase-free 1× PBS.
Mix 25 μL of Triton X-100, 50 μL of 1 M DTT, 50 μL of Superase-InTM RNase inhibitor, and 50 mL of RNase-free 1× PBS.
Acknowledgments
Michael A. Cortázar was a scholar of the University of Colorado at Denver RNA Bioscience Initiative. Labeling and immunoprecipitation steps in this protocol were modified from the Bru-Seq protocol (Paulsen et al., 2014). This work was supported by a NIH grant R35 GM144336 to D.B.
Competing interests
The authors declare no competing interests.
References
Article Information
Copyright
© 2023 The Author(s); This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/).
How to cite
Cortázar, M. A., Fong, N. and Bentley, D. L. (2023). Genome-wide Mapping of 5′-monophosphorylated Ends of Mammalian Nascent RNA Transcripts. Bio-protocol 13(18): e4828. DOI: 10.21769/BioProtoc.4828.
Category
Molecular Biology > RNA > RNA sequencing
Molecular Biology > RNA > RNA synthesis
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link